Ascent Group LLC Takes $344,000 Position in Mettler-Toledo International, Inc. $MTD

Key Points

• Ascent Group LLC has invested approximately $344,000 in Mettler-Toledo International, acquiring 291 shares, according to a recent SEC filing.
• Institutional ownership in Mettler-Toledo International is notably high at 95.07%, with several firms, including Vanguard Group and GAMMA Investing, increasing their holdings during the first quarter.
• Mettler-Toledo's stock is currently trading at $1,280.28 and has a market capitalization of $26.37 billion, with the firm expecting to post an EPS of 42.71 for the current fiscal year.

Ascent Group LLC purchased a new stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 291 shares of the medical instruments supplier's stock, valued at approximately $344,000.

A number of other large investors also recently made changes to their positions in MTD. WPG Advisers LLC bought a new position in Mettler-Toledo International during the first quarter worth about $41,000. Zions Bancorporation National Association UT bought a new position in Mettler-Toledo International during the first quarter worth about $43,000. Golden State Wealth Management LLC lifted its holdings in Mettler-Toledo International by 583.3% during the first quarter. Golden State Wealth Management LLC now owns 41 shares of the medical instruments supplier's stock worth $48,000 after acquiring an additional 35 shares in the last quarter. Menard Financial Group LLC bought a new position in Mettler-Toledo International during the fourth quarter worth about $67,000. Finally, Blue Trust Inc. lifted its holdings in Mettler-Toledo International by 520.0% during the first quarter. Blue Trust Inc. now owns 62 shares of the medical instruments supplier's stock worth $73,000 after acquiring an additional 52 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the business's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the completion of the sale, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. The trade was a 5.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the sale, the director owned 283 shares of the company's stock, valued at approximately $368,154.70. This represents a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,827 shares of company stock worth $2,371,208 over the last quarter. Company insiders own 0.77% of the company's stock.

Analyst Ratings Changes

Several research analysts have weighed in on the company. Bank of America lifted their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a report on Thursday, June 26th. Barclays started coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target on the stock. Robert W. Baird lifted their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Evercore ISI dropped their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research note on Monday, August 4th. Finally, Citigroup raised their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. Five research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $1,311.11.

Mettler-Toledo International Stock Performance

Mettler-Toledo International stock traded up $2.68 during midday trading on Monday, reaching $1,262.22. 109,653 shares of the company's stock were exchanged, compared to its average volume of 169,238. Mettler-Toledo International, Inc. has a 52 week low of $946.69 and a 52 week high of $1,521.01. The firm has a market cap of $26.00 billion, a price-to-earnings ratio of 31.96, a P/E/G ratio of 3.78 and a beta of 1.37. The stock's 50-day simple moving average is $1,258.94 and its 200 day simple moving average is $1,184.82.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million during the quarter, compared to analysts' expectations of $957.41 million. During the same quarter in the previous year, the company posted $9.65 earnings per share. The business's revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.